Abstract
After 3 years of co-design with stakeholders and EU regulatory partners, the European Medicines Agency’s Regulatory Science to 2025 strategy has been finalized. Here, we highlight the core recommendations that stakeholders deem most significant to advance evidence generation.
Cite
CITATION STYLE
APA
Hines, P. A., Janssens, R., Gonzalez-Quevedo, R., Lambert, A. I. O. M., & Humphreys, A. J. (2020, May 1). A future for regulatory science in the European Union: the European Medicines Agency’s strategy. Nature Reviews Drug Discovery. Nature Research. https://doi.org/10.1038/d41573-020-00032-0
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free